Literature DB >> 22305321

Bevacizumab for ROP.

Michael Blair, Michael J Shapiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22305321     DOI： 10.1016/j.ophtha.2011.11.021

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  2 in total

1.  Smouldering retinopathy of prematurity: a case treated by multiple antivascular endothelial growth factor therapy.

Authors:  Divya Balakrishnan; Vikas Ambiya; Subhadra Jalali; Padmaja Kumari Rani
Journal:  BMJ Case Rep       Date:  2016-08-29

2.  Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options.

Authors:  Fatih Mehmet Mutlu; Serdar Umit Sarici
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.